KPRC in Houston Warns People of Potential Dangers of Using Topamax, Other Medications in Conditions of Extreme Heat, the Consumer Justice Foundation Reports

Share Article

The Consumer Justice Foundation, a for-profit corporation that is staffed by a team of professional consumer advocates whose mission is to provide the public with free online informational resources regarding the potential dangers associated with certain prescription medications, has a Web site located at the URL of The Consumer Justice Foundation hereby alerts the public of a report released by KPRC in Houston stating that using medications including Topamax in conditions of extreme heat can involve serious risks to those who do so.

The Consumer Justice Foundation, a for-profit corporation whose team of professional consumer advocates provide free online educational resources to the public regarding the potential dangers associated with the use of certain prescription medications, hereby alerts the public of a report released by television station KPRC in Houston, Texas that warns of the potential dangers of using Topamax in conditions of extreme heat.

Specifically, the report was published on June 26, 2012 and it states that using Topamax can exaggerate the body’s response to heat, which is of particular concern in that area given the high temperatures that have been in place recently. This alleged Topamax side effect was mentioned along with the dangers of using heart drugs such as beta-blockers and diuretics.

The body’s response to heat can be exaggerated such that a person will sweat excessively, become dehydrated and eventually progress into health risks that include heat exhaustion or heat stroke, where organs begin to malfunction. At this point, danger exists and people experiencing these problems need immediate medical attention.

Topamax is known as an anticonvulsant medication that is used to treat migraine headaches and epileptic seizures. It is manufactured by Ortho-McNeil, which is a subsidiary of Johnson & Johnson. It was originally approved for use in treatment of epilepsy in 1996 by the FDA and it was approved in 2004 for treatment of migraine headaches.

This latest alleged Topamax side effect comes on the heels of the FDA issuing a statement requiring stronger warnings for users of the drug regarding the potential dangers faced by women who use it early during their pregnancies and their higher risk of having children born with birth defects. Topamax has been classified as a Category D pregnancy medication, which means that there is evidence of fetal risk but the benefits of the drug may still outweigh the risks in certain situations.

About the Consumer Justice Foundation

The Consumer Justice Foundation, whose Web site can be found at, is a for-profit organization that serves two purposes for consumers: (1) to provide educational information regarding the policies and procedures of large corporations and how they affect the average consumer; and (2) to provide news updates and resources that continue to update consumers regarding developments taken by corporations that include pharmaceutical drug companies, auto manufacturers and insurance companies so that consumers who have been harmed can use these informational resources to connect to an experienced professional who can help them. The team at the Consumer Justice Foundation is staffed by experienced and passionate consumer advocates whose mission is to raise the awareness of issues that could pose a risk of harm to those who may not otherwise be aware of the dangers they face.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Faith Anderson
Visit website